Abstract:e20558 Background: With the recommendation of high-resolution chest computed tomography scan in lung cancer screening, multiple primary lung cancers (MPLC) is gaining more attention. Identifying MPLC from intrapulmonary metastases (IPM) is crucial to the clinical management. The current guidelines for the identification are always based on expert consensus rather than clinical evidence. We aim to develop a reliable identification method and further figure out the clinical and genetic features of MPLC. Methods: We retrospectively screened 305 lung lesions from 131 patients who underwent radical resection for multiple lung carcinomas. To minimize the effect of therapeutic intervention on prognostic outcomes, patients with each single tumor size smaller than 4cm, free of nodal or systemic metastases, and had high-quality whole-exon sequencing (WES) data were included. We selected 11 patients with confirmed intrapulmonary metastases for training. All patients’ follow-up information was collected until disease recurrence or metastases. A WES genetic divergence method for identifying MPLC from IPM was developed. The disease-free survival (DFS) was used as a validation tool for identification reliability. Results: A total of 61 eligible multi-lesion patients with 128 resected non-small cell lung cancer (NSCLC) lesions were finally analyzed. Based on WES genetic divergence identification, 51 MPLC patients were identified, whose DFS was significantly prolonged (HR, 0.27; 95% CI, 0.08 to 0.91; P = 0.02), while other recommended methods for identifying MPLC patients failed to show a DFS advantage. Among MPLC patients, 43.1% (22/51) had a first-degree relatives cancer family history, of whom 54.5% (12/22) had a lung cancer family history. EGFR was still the most common mutation gene (72.5%, 37/51); however, TP53 mutations was less frequent in MPLC (21% vs. 48%, P < 0.05), and tumor mutation burden (TMB) was lower (median, 0.73 muts/Mb vs. 1.15 muts/Mb, P < 0.01). Notably, despite the lack of shared alterations, unique germline variants in cancer-predisposing genes, particularly nonsynonymous SNV in solute carrier gene (SLC) family, were observed in most MPLC patients, rarely overlapping with IPM patients. Conclusions: WES-based genetic divergence clearly distinguishes independent primary tumors from IPM in NSCLC patients. MPLC patients represent a unique population which deserves further study.

[Study on 21 Cases of Multiple Primary Lung Cancer].

Advances in Diagnosis and Treatment of Multiple Primary Lung Cancer

Diagnosis and management of multiple primary lung cancer

Multiple primary lung cancer: a rising challenge

A Comprehensive Algorithm to Distinguish Between MPLC and IPM in Multiple Lung Tumors Patients.

Differential Diagnosis and Treatment Option of Multiple Primary Lung Cancer

Multiple Primary Lung Cancers: A New Challenge in the Era of Precision Medicine.

Real‐world comprehensive diagnosis and "Surgery + X" treatment strategy of early‐stage synchronous multiple primary lung cancer

[Recent Advances in Diagnosis and Treatment Strategies for Multiple Primary Lung Cancer]

Clinical diagnostic criteria, stage classification, and treatment strategy for multiple primary lung cancer

Clinical and Molecular Characteristics of Multiple Primaries Identified by Whole-Exome Sequencing-Based Genetic Divergence in Non-Small-cell Lung Cancer

Phenotype-genotype Correlation in Multiple Primary Lung Cancer Patients in China

Multiple primary lung cancer versus intrapulmonary metastatic cancer: A case of multiple pulmonary nodules

The Report of 27 Cases of Non-small Cell Lung Cancer in Multiple Primary Cancer

Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data

Radiological classification, gene-mutation status, and surgical prognosis of synchronous multiple primary lung cancer

Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers

[Clinical Features and Treatment Outcome of Multiple Primary Lung Cancer Patients with Different Imaging Performance].

Immunohistochemistry combined with NGS to assist the differential diagnosis of multiple primary lung cancer with lymph node metastasis: a case report

Clinical Diagnosis and Treatment of Multiple Pulmonary Nodules

Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases